Recovery Act – Comparative Effectiveness Research - AHRQ

Inactive

Assistance listing
93.715
Agency
Grant awards
109 $303,113,166 in federal obligations

Program facts

Assistance types
  • Project Grant
  • Cooperative Agreement
Eligible applicants
  • Federal
  • Non-Government - General
  • State (includes District of Columbia, public institutions of higher education and hospitals)
  • Public nonprofit institution/organization (includes institutions of higher education and hospitals)
  • Local (includes State-designated lndian Tribes, excludes institutions of higher education and hospitals
  • Federally Recognized lndian Tribal Governments
Beneficiaries
  • Private nonprofit institution/organization
  • Local
  • Sponsored organization
  • Anyone/general public
  • State
  • Other public institution/organization
  • Specialized group (e.g. health professionals, students, veterans)
  • Scientist/Researchers
  • Health Professional
  • Individual/Family
  • Native American Organizations
  • Consumer
  • Federally Recognized Indian Tribal Governments
  • Education Professional
  • Student/Trainee
  • Minority group
  • Public nonprofit institution/organization

Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.

About this program

The Agency for Healthcare Research and Quality (AHRQ) under the Department of Health and Human Services made its most recent awards under the Recovery Act – Comparative Effectiveness Research program (CFDA 93.715) on September 30, 2010, making this program inactive for the past 16 years. The program funded comparative effectiveness research comparing different interventions and strategies to prevent, diagnose, treat, and monitor health conditions, supported through the American Recovery and Reinvestment Act of 2009.

The program is no longer active. AHRQ obligated $303.1 million across 109 total awards, with 108 awards made in 2010 and one in 2009. This represents a single-year funding surge characteristic of Recovery Act stimulus programming rather than an ongoing solicitation cycle.

Awards were predominantly Project Grants (99 percent), with one Cooperative Agreement comprising the remainder. AHRQ was the sole funding agency. Award magnitudes ranged widely, from under $400 thousand to $11.7 million. Representative funded activities included comparative effectiveness networks such as the Scalable Architecture for Federated Therapeutic Inquiries Network ($8.3 million), disease-specific comparisons including bipolar disorder treatment ($9.8 million) and back pain outcomes ($9.9 million), pediatric chronic disease registries ($11.7 million), emergency care practice comparisons ($1.4 million), and diabetes intervention effectiveness studies ($3.0 million). The program also supported research infrastructure, dissemination networks, and community health worker delivery models.

No current grant opportunities are available under this program. The Recovery Act–funded comparative effectiveness research initiative concluded its funding cycle more than a decade ago. Organizations seeking AHRQ comparative effectiveness funding should evaluate active successor programs, as this listing is no longer soliciting new applications.

Objective and description

Objective

To improve health outcomes by providing evidence to enhance medical decisions made by patients and their medical providers. This goal is pursued by generating research comparing different interventions and strategies to prevent, diagnose, treat and monitor health conditions. Funds are available under the American Recovery and Reinvestment Act of 2009 to support research and evaluations, demonstration projects, research networks and multidisciplinary centers, predoctoral and postdoctoral training opportunities, individual fellowships, and to disseminate rigorous evaluations of the impact of different options that are available for treating a given medical condition for a particular set of patients.

Grant awards

Latest 10 of 109 listed here. See the rest on GovTribe.

Top recipients by federal obligations

10 of 70 recipients listed here. See the rest on GovTribe.

Federal obligations by fiscal year

Fiscal year Federal obligations
FY2013 -$27,000
FY2012 -$876,250
FY2011 -$313,274
FY2010 $311,210,480
FY2009 $296,669

Quick answers

What is Assistance Listing 93.715?

Assistance Listing 93.715 is Recovery Act – Comparative Effectiveness Research - AHRQ, a federal grant program run by Agency for Healthcare Research and Quality (Department of Health and Human Services). It is inactive.

What is the CFDA number for Recovery Act – Comparative Effectiveness Research - AHRQ?

Its CFDA number is 93.715: Assistance Listing numbers were called CFDA numbers before 2018.

How much funding has Assistance Listing 93.715 awarded?

109 grant awards under 93.715 have obligated $303,113,166 in federal funds to 70 recipients.

Who receives the most funding from 93.715?

The recipients obligated the most under Recovery Act – Comparative Effectiveness Research - AHRQ are Kaiser Foundation Hospitals ($41,272,410), University Of Washington ($23,283,883) and The Trustees Of Columbia University In The City Of New York ($18,033,184).

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program